These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 4931286
1. Rat heart allograft survival with donor pretreatment. Freeman JS, Chamberlain E, Reemtsma K, Steinmuller D. Circulation; 1971 May; 43(5 Suppl):I120-3. PubMed ID: 4931286 [No Abstract] [Full Text] [Related]
4. Prolongation of rat heart allografts by donor pretreatment with immunosuppressive agents. Freeman JS, Chamberlain EC, Reemtsma K, Steinmuller D. Transplant Proc; 1971 Mar; 3(1):580-2. PubMed ID: 4937943 [No Abstract] [Full Text] [Related]
5. Manipulation of allograft immunogenicity by pretreatment of cadaver donors. Guttmann RD. Urol Clin North Am; 1976 Oct; 3(3):475-90. PubMed ID: 790729 [Abstract] [Full Text] [Related]
6. Effects of cell membranes with and without antilymphocyte serum on skin and heart allograft survival. Matolo NM, Reemtsma K, Dewitt CW. Transplantation; 1972 Mar; 13(3):265-9. PubMed ID: 4553728 [No Abstract] [Full Text] [Related]
7. Prolongation of allograft survival by donor irradiation. Kyger ER, Salyer KE, Ecker RR, Webb WR. Surg Forum; 1970 Mar; 21():288-9. PubMed ID: 4936986 [No Abstract] [Full Text] [Related]
8. Experimental evaluation of various methods used for prolongation of skin homografts--studies done in rats and rabbits. Gupta RL, Rao VJ, Munje RR. Indian J Med Res; 1972 Aug; 60(8):1196-204. PubMed ID: 4574913 [No Abstract] [Full Text] [Related]
10. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat. Winearls CG, Fabre JW, Millard PR, Morris PJ. Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937 [Abstract] [Full Text] [Related]
12. Homograft rejection delayed by treatment of donor tissue in vitro with antilymphocyte serum. Burde RM, Waltman SR, Berrios JH. Science; 1971 Sep 03; 173(4000):921-3. PubMed ID: 4937230 [Abstract] [Full Text] [Related]
13. Inhibition of skin allograft rejection by antilymphocytic serum pretreatment of the donor. Immunological preparation of the graft. Petrányi G, Szegedi G, Fekete B. Acta Med Acad Sci Hung; 1971 Sep 03; 28(2):155-8. PubMed ID: 4948114 [No Abstract] [Full Text] [Related]
14. Suppression of corneal graft reaction by antilymphocyte serum. 3. Effect of pretreatment of donor animals. Smolin G, Hyndiuk RA. Arch Ophthalmol; 1971 Apr 03; 85(4):451-4. PubMed ID: 4929072 [No Abstract] [Full Text] [Related]
15. Specific inhibition of organ allograft rejection by donor blood. Marquet RL, Heystek GA, Tinbergen WJ. Transplant Proc; 1971 Mar 03; 3(1):708-10. PubMed ID: 4937963 [No Abstract] [Full Text] [Related]
16. Cardiac transplantation in mice. IV. Relationship between antithymocyte-globulin (ATG) dose, allograft survival and anti-ATG immunity. Judd KP, Bryant CJ, Ruckman RJ, Trentin JJ. Rev Eur Etud Clin Biol; 1971 Dec 03; 16(10):1002-6. PubMed ID: 4400851 [No Abstract] [Full Text] [Related]
17. Adjuvant immunosuppression in renal transplantation: high dose intravenous steroids, local radiation therapy, and antilymphocyte globulin. Turcotte JG, Freier DT, Dickerman R. Urol Clin North Am; 1976 Oct 03; 3(3):597-610. PubMed ID: 790733 [No Abstract] [Full Text] [Related]
18. Evaluation of antilymphocyteserum: comparison of skinallograft survival and rosette inhibition. Kissling M, Speck B. Experientia; 1973 May 01; 29(1):105-6. PubMed ID: 4580889 [No Abstract] [Full Text] [Related]
19. Bone marrow grafts and histocompatibility. Amiel JL, Schwarzenberg L, Mathé G. Transplant Proc; 1971 Jun 01; 3(2):1072-7. PubMed ID: 4400010 [No Abstract] [Full Text] [Related]
20. A human case of allogeneic heart transplantation compatible in the HL-A system and treated by a heterologous anti-lymphocyte globulin. Dubost C, Cachera JP. Transplant Proc; 1969 Jun 01; 1(2):693-702. PubMed ID: 4107071 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]